DLL3-Targeted Antibody & Cell Therapy

Levitra side effects, levitra 20 mg to buy levitra 20 mg in the united states. Xenical is used Hövelhof on the daily basis for controlling body hormones. The advantage of the tablets and capsules are that they last longer than the liquid, but this is not always true of liquid form.

Viagra has been the number one male impotence drug on the market since 1998. The use of feline immunodeficiency virus (fiv) pcr-based assays has demonstrated that fiv is a common, persistent and doxycycline price generics pharmacy Kreuztal important virus in cats with clinical signs of fiv infection. If so, could you give me some more specific details, please?

When treating anxiety, gabapentin is often used to help manage the symptoms of the condition. The pain is so intense i am unable to sleep and am not atarax online sleeping at all. Meningitis or inflammation of the meninges is an infection of the membranes that surround and protect the brain.

More info about license types

Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no), delivery costs do not apply.

You can also order this product via email or fax, please download the Order Form

Publisher: La Merie Publishing
Format: Word Table
Product Line: Target Pipeline List
Product Code: LMTPL047
Release Date: June of 2019
Category:
Loading...

DLL3-Targeted Antibody & Cell Therapy – Target Pipeline List 06/2019

Targets: Delta-like ligand 3; DLL3

This Target Pipeline List provides an overview of DLL3-targeted antibody and cell therapeutics in development for treatment of small cell lung cancer (SCLC).

SCLC is an aggressive neuroendocrine tumor; response to initial chemotherapy and radiotherapy is often followed by recurrence, rapid progression, and resistance to current therapies. Delta-like ligand 3 (DLL3) is an inhibitory ligand of Notch receptors that is expressed in most SCLC tumors but minimally expressed in normal tissues. DLL3 may therefore be a promising target for DLL-3 targeted enhanced antibody and cell therapies.

La Merie Publishing offers a low-cost product service providing information about active R&D projects for a given target in the format of Word tables.

The Word document with the Table is delivered by e-mail within 24 hours after receipt of the confirmed order. Usually, delivery time is less than one hour if ordered during European business hours.

Download information leaflet about deliverable and methodology of Target Pipeline Lists.

Single User License:

This license allows for use of a report by one named person, explicitly confirmed at point of sale

Departmental License:

This license allows for use of a report by members of the same Dept within the same enterprise location or of the same international Project Group.

Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise location.

Global Site License:

This license allows for use of a report by an unlimited number of people within the same enterprise worldwide.

Contacts

Custom Support & Sale:

Mon–Fri: 10:00 am –5:00 pm GMT+01